PubMed

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.

Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N.

Ann Intern Med. 2003 Feb 4;138(3):176-86.PMID: 12558356 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus.

[No authors listed]

Ann Intern Med. 2003 Feb 4;138(3):I-41. No abstract available. PMID: 12558382 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.

Gerson LB, Groeneveld PW, Triadafilopoulos G.

Clin Gastroenterol Hepatol. 2004 Oct;2(10):868-79.PMID: 15476150 [PubMed - indexed for MEDLINE]Related articles

Defining a clinically significant adverse impact of diagnosing Barrett's esophagus.

Rubenstein JH, Inadomi JM.

J Clin Gastroenterol. 2006 Feb;40(2):109-15.PMID: 16394870 [PubMed - indexed for MEDLINE]Related articles

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.PMID: 16545207 [PubMed - indexed for MEDLINE]Related articlesFree article

Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

Provenzale D, Schmitt C, Wong JB.

Am J Gastroenterol. 1999 Aug;94(8):2043-53.PMID: 10445526 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of screening a population with chronic gastroesophageal reflux.

Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, Hawes RH, Wallace MB.

Gastrointest Endosc. 2003 Mar;57(3):311-8.PMID: 12612508 [PubMed - indexed for MEDLINE]Related articles

Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.

Gerson L, Lin OS.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):319-25.PMID: 17368231 [PubMed - indexed for MEDLINE]Related articles

A guide for surveillance of patients with Barrett's esophagus.

Provenzale D, Kemp JA, Arora S, Wong JB.

Am J Gastroenterol. 1994 May;89(5):670-80.PMID: 8172136 [PubMed - indexed for MEDLINE]Related articles

Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.

Rubenstein JH, Inadomi JM, Brill JV, Eisen GM.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):312-8.PMID: 17368230 [PubMed - indexed for MEDLINE]Related articles

Are screening and surveillance for Barrett's oesophagus really worthwhile?

Sharma P, Sidorenko EI.

Gut. 2005 Mar;54 Suppl 1:i27-32. Review.PMID: 15711005 [PubMed - indexed for MEDLINE]Related articlesFree article

The wizards of odds: cost-effectiveness, Barrett's screening, and surveillance guidelines.

Perdue DG, Murray J, Wang KK.

Clin Gastroenterol Hepatol. 2004 Oct;2(10):865-7. No abstract available. PMID: 15476149 [PubMed - indexed for MEDLINE]Related articles

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Shaheen N, Ransohoff DF.

JAMA. 2002 Apr 17;287(15):1972-81. Review.PMID: 11960540 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85. Epub 2005 Jan 4.PMID: 15829317 [PubMed - indexed for MEDLINE]Related articles

Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?

Soni A, Sampliner RE, Sonnenberg A.

Am J Gastroenterol. 2000 Aug;95(8):2086-93.PMID: 10950062 [PubMed - indexed for MEDLINE]Related articles

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM.

JAMA. 1999 May 19;281(19):1822-9.PMID: 10340370 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.

Vij R, Triadafilopoulos G, Owens DK, Kunz P, Sanders GD.

Gastrointest Endosc. 2004 Nov;60(5):739-56.PMID: 15557950 [PubMed - indexed for MEDLINE]Related articles

Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.

Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R.

Cancer. 2007 Feb 15;109(4):668-74.PMID: 17211862 [PubMed - indexed for MEDLINE]Related articlesFree article

[Recommended endoscopic surveillance of patients with Barrett's esophagus (BE) is a cost-effective strategy?]

Remes-Troche JM, Ramírez-Arias JF, Gómez-Escudero O, Valdovinos-Andraca F, Vargas-Vorácková F.

Rev Gastroenterol Mex. 2006 Jan-Mar;71(1):46-54. Spanish. PMID: 17061478 [PubMed - indexed for MEDLINE]Related articles

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article